Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04188392 · ClinicalTrials.gov registry record · Phase 4
Pimavanserin for Insomnia In Veterans With Posttraumatic Stress Disorder
A Phase 4 study, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- Phase 4
- Development phase
- 6
- Enrollment target
NCT04188392: Completed Phase 4 study, sponsored by Baylor College of Medicine.
NCT04188392 is a Phase 4 study that has completed, run by Baylor College of Medicine. The registered enrollment target is 6 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04188392, a Phase 4 study, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 6 participants
- Enrollment target
Study Summary
This preliminary, open-label study assesses the feasibility of 34mg at bedtime for 6 weeks in Veterans with Posttraumatic Stress Disorder and insomnia.
Primary Outcome
The rate of enrollment per month; goal of 6 subjects total
Interventions
- DRUG Pimavanserin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2020-01-06 |
| Est. Completion | 2021-11-10 |
| Phase | Phase 4 |
What the finished NCT04188392 record still lists
NCT04188392 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Pimavanserin is the first listed.
NCT04188392 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04188392 about?
NCT04188392 is a clinical study titled "Pimavanserin for Insomnia In Veterans With Posttraumatic Stress Disorder". This preliminary, open-label study assesses the feasibility of 34mg at bedtime for 6 weeks in Veterans with Posttraumatic Stress Disorder and insomnia.
What is the current status of trial NCT04188392?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 6 participants. The study started on 2020-01-06. Estimated completion is 2021-11-10.
What interventions are being tested in trial NCT04188392?
The interventions under investigation include: Pimavanserin (DRUG).
Who is sponsoring clinical trial NCT04188392?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04188392's enrollment target sits among peer trials
6 1983rd of 2000 higher than 12 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI